Symposium Vaccine Delivery and Immune Response
Key discussions will delve into the impact of various vaccine formulations and delivery routes on immune responses and the necessity of tailoring administration routes, such as intradermal, mucosal, intramuscular, and more to achieve optimal outcomes for the prevention of disease and/or its transmission.
Participants will discover how different delivery methods can be strategically selected based on knowledge about the infection routes of target pathogens, enhancing the efficacy and specificity of immunization efforts. The symposium may also address the importance of adjuvant selection and the role of advanced technologies like lipid nanoparticles in vaccine formulation.
Furthermore, we will examine how latest advancements in vaccine delivery and the potential of alternative administration routes, such as oral vaccines, can revolutionize public health strategies and (pandemic) vaccination programs.
Join us for this unique opportunity to engage with cutting-edge research and contribute to the evolving landscape of vaccine development and immune response optimization.
PRELIMINARY PROGRAMME
We will kick off the symposium with a Keynote presentation: Setting the scene - Exploring Delivery Routes: Impact on Immune Response, Challenges, and Emerging Trends.
This will be followed by two engaging sessions featuring a series of short talks. In the first session, four distinguished academic speakers will present their research on mucosal vaccines, RNA vaccine delivery, and other related topics.
The second session will showcase innovative results and technologies from leading companies in the field of vaccine delivery, with applications in vaccination and immunotherapy.
Topics that will be addressed during the symposium:
Aligning the vaccination route with the desired immune response
Choosing the vaccination route based on the pathogen’s infection route
Immune response for different vaccination routes: intravenous, intramuscular, intraperitoneal, oral, nasal, pulmonary, intradermal,…
Selecting adjuvants based on the vaccination route and lipid nanoparticles (LNPs)
Choosing the vector/vaccine platform based on the vaccination route
Devices for different vaccination routes